Tumor necrosis factor-alpha promotes survival in methotrexate-exposed macrophages by an NF- Kappa B-dependent pathway

Introduction: Methotrexate (MTX) induces macrophage apoptosis in vitro, but there is not much evidence for increased synovial macrophage apoptosis in MTX-treated patients. Macrophage apoptosis is reported, however, during clinical response to anti-tumor necrosis factor-alpha (TNF- alpha ) treatments...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis research & therapy 2011-01, Vol.13 (1)
Hauptverfasser: Lo, SZY, Steer, J H, Joyce, DA
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: Methotrexate (MTX) induces macrophage apoptosis in vitro, but there is not much evidence for increased synovial macrophage apoptosis in MTX-treated patients. Macrophage apoptosis is reported, however, during clinical response to anti-tumor necrosis factor-alpha (TNF- alpha ) treatments. This implies that TNF- alpha promotes macrophage survival and suggests that TNF- alpha may protect against MTX-induced apoptosis. We, therefore, investigated this proposal and the macrophage signaling pathways underlying it. Methods: Caspase-3 activity, annexin-V binding/7-aminoactinomycin D (7-AAD) exclusion and cell-cycle analysis were used to measure steps in apoptosis of primary murine macrophages and cells of the RAW sub(264.7) macrophage cell line that had been exposed to clinically-relevant concentrations of MTX and TNF- alpha . Results: MTX induces apoptosis in primary murine macrophages at concentrations as low as 100 nM in vitro. TNF- alpha , which has a context-dependent ability to increase or to suppress apoptosis, efficiently suppresses MTX-induced macrophage apoptosis. This depends on NF- Kappa B signaling, initiated through TNF Receptor Type 1 ligation. Macrophage colony stimulating factor, the primary macrophage survival and differentiation factor, does not activate NF- Kappa B or protect macrophages from MTX-induced apoptosis. A weak NF- Kappa B activator, Receptor Activator of NF- Kappa B Ligand (RANKL) is likewise ineffective. Blocking NF- Kappa B in TNF- alpha -exposed macrophages allowed pro-apoptotic actions of TNF- alpha to dominate, even in the absence of MTX. MTX itself does not promote apoptosis through interference with NF- Kappa B signaling. Conclusions: These findings provide another mechanism by which TNF- alpha sustains macrophage numbers in inflamed tissue and identify a further point of clinical complementarity between MTX and anti-TNF- alpha treatments for rheumatoid arthritis.
ISSN:1478-6354
DOI:10.1186/ar3248